PRODUCT DESCRIPTION
PT-141, also known as bremelanotide, is a unique research peptide because it acts on desire and arousal pathways in the brain rather than working only through local blood flow. By activating specific melanocortin receptors, it has been studied for its potential influence on sexual desire, arousal, erectile response, and the neurological signals involved in sexual function.
Potential research benefits
- Increased sexual desire: PT-141 has been studied for its ability to increase desire by acting on the brain's sexual-response system rather than relying only on physical stimulation.
- Improved arousal and responsiveness: Human research has reported encouraging changes in arousal and sexual satisfaction in selected study groups.
- Support for erectile response: Studies in men have shown that melanocortin activation can produce a measurable erectile response through a mechanism different from common blood-flow-focused compounds.
- Potential for both male and female research: Because PT-141 works centrally, it has attracted interest across a wider range of sexual-function research involving both sexes.
- A genuinely different research pathway: Its action on MC3 and MC4 receptors gives scientists a unique tool for studying the connection between the brain, desire, and physical sexual response.
Why researchers are interested
PT-141 has been evaluated in multiple human trials, with researchers reporting measurable improvements in sexual desire and response in selected study populations. Its central mechanism makes it one of the most distinctive and well-studied peptides in sexual-function research.